Default: Current Opinion in Oncology

ISSN: 1040-8746

Journal Home

Journal Guideline

Current Opinion in Oncology Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 96. It has an SJR impact factor of 1.022 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1.022.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

- €

Non OA


Current Opinion in Oncology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

Best articles by citations

Fluorescence resonance energy transfer in the study of cancer pathways

View more

Statistical methods applied to omics data

View more

Emerging new anticancer therapies in 2013

View more

Mapping genetic alterations in tumors with single nucleotide polymorphisms

View more

Chronic myelogenous leukemia

View more

Giant cell tumour of bone

View more

List of journals scanned

View more

Defining locally advanced basal cell carcinoma and integrating smoothened inhibitors into clinical practice

View more

Update: gastric MALT lymphoma

View more

Of art and science

View more

The role of surgical resection in patients with brain metastases

View more

Ocular manifestations of central nervous system lymphoma

View more

Surveillance recommendations for patients with germline TP53 mutations

View more

New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia

View more

Treatment of patients with early epithelial ovarian cancer

View more

Acute progranulocytic leukemia

View more

Recent developments in supporting adolescent and young adult siblings of cancer patients

View more

Costimulatory approaches to adoptive immunotherapy

View more

Cellular adoptive immunotherapy after allogeneic stem cell transplantation

View more

Targeting the molecular target of rapamycin (mTOR)

View more

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies

View more

Recent advances in pediatric acute lymphoblastic and myeloid leukemia

View more

Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment

View more

Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha

View more